Citations 1
Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)
Rué, Montserrat , Blood, Emily, Kaminer, Lynne, Vesole, David H. , Greipp, Philip R., Gertz, Morie A.
Leukemia & Lymphoma | August 12, 2004 | Volume: 45 | Issue: 10 | Pages: 2047-2055
